218 related articles for article (PubMed ID: 32298325)
1. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
Ulyte A; Wei W; Dressel H; Gruebner O; von Wyl V; Bähler C; Blozik E; Brüngger B; Schwenkglenks M
PLoS One; 2020; 15(4):e0231409. PubMed ID: 32298325
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study.
Bähler C; Brüngger B; Ulyte A; Schwenkglenks M; von Wyl V; Dressel H; Gruebner O; Wei W; Blozik E
BMC Public Health; 2021 Jan; 21(1):23. PubMed ID: 33402140
[TBL] [Abstract][Full Text] [Related]
3. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
[TBL] [Abstract][Full Text] [Related]
4. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
[TBL] [Abstract][Full Text] [Related]
5. Adherence to cancer screening guidelines across Canadian provinces: an observational study.
Strumpf EC; Chai Z; Kadiyala S
BMC Cancer; 2010 Jun; 10():304. PubMed ID: 20565862
[TBL] [Abstract][Full Text] [Related]
6. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
7. Disparities in colorectal cancer screening among breast and prostate cancer survivors.
Dash C; Lu J; Parikh V; Wathen S; Shah S; Shah Chaudhari R; Adams-Campbell L
Cancer Med; 2021 Feb; 10(4):1448-1456. PubMed ID: 33544443
[TBL] [Abstract][Full Text] [Related]
8. Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.
Raffin E; Onega T; Bynum J; Austin A; Carmichael D; Bronner K; Goodney P; Hyams ES
Cancer Epidemiol; 2017 Oct; 50(Pt A):68-75. PubMed ID: 28822325
[TBL] [Abstract][Full Text] [Related]
9. Utilization and Cost of Mammography Screening Among Commercially Insured Women 50 to 64 Years of Age in the United States, 2012-2016.
Khushalani JS; Ekwueme DU; Richards TB; Sabatino SA; Guy GP; Zhang Y; Tangka F
J Womens Health (Larchmt); 2020 Mar; 29(3):327-337. PubMed ID: 31613693
[No Abstract] [Full Text] [Related]
10. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
11. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
[TBL] [Abstract][Full Text] [Related]
12. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
[TBL] [Abstract][Full Text] [Related]
13. Degree of regional variation and effects of health insurance-related factors on the utilization of 24 diverse healthcare services - a cross-sectional study.
Wei W; Ulyte A; Gruebner O; von Wyl V; Dressel H; Brüngger B; Blozik E; Bähler C; Braun J; Schwenkglenks M
BMC Health Serv Res; 2020 Nov; 20(1):1091. PubMed ID: 33246452
[TBL] [Abstract][Full Text] [Related]
14. Are U.S. cancer screening test patterns consistent with guideline recommendations with respect to the age of screening initiation?
Kadiyala S
BMC Health Serv Res; 2009 Oct; 9():185. PubMed ID: 19821991
[TBL] [Abstract][Full Text] [Related]
15. Association Between Online Information-Seeking and Adherence to Guidelines for Breast and Prostate Cancer Screening.
Kim H; Filson C; Joski P; von Esenwein S; Lipscomb J
Prev Chronic Dis; 2018 Apr; 15():E45. PubMed ID: 29679480
[TBL] [Abstract][Full Text] [Related]
16. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
[TBL] [Abstract][Full Text] [Related]
17. Medicare Cancer Screening in the Context of Clinical Guidelines: 2000 to 2012.
Maroongroge S; Yu JB
Am J Clin Oncol; 2018 Apr; 41(4):339-347. PubMed ID: 26886947
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
19. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
20. The impact of Medicare eligibility on cancer screening behaviors.
Meyer CP; Allard CB; Sammon JD; Hanske J; McNabb-Baltar J; Goldberg JE; Reznor G; Lipsitz SR; Choueiri TK; Nguyen PL; Weissman JS; Trinh QD
Prev Med; 2016 Apr; 85():47-52. PubMed ID: 26763164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
